US study finds GLP-1 weight-loss prescriptions for under-12s up 300-fold
A study published Friday says U.S. prescriptions for GLP-1 weight-loss drugs among children under 12 have risen more than 300-fold since 2019, as doctors seek effective treatments for younger patients with obesity.
Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have increased more than 300-fold since 2019, according to a study published on Friday, as doctors look for new and effective treatments for younger patients with obesity. The study included more than 3.5 million children aged 1 to 12.